Recruiting × Lymphoma × Other hematologic neoplasm × Clear all Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Phase 2 Recruiting
80 enrolled
ACCELERATE
Phase 2 Recruiting
358 enrolled
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Phase 1/2 Recruiting
160 enrolled
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Phase 1 Recruiting
572 enrolled
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Phase 2 Recruiting
100 enrolled
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Phase 1/2 Recruiting
126 enrolled
QUADvance
Phase 1/2 Recruiting
178 enrolled
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Recruiting
1,000 enrolled
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Recruiting
60 enrolled
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Recruiting
88 enrolled
REALIZE
Phase 1 Recruiting
60 enrolled
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Phase 1/2 Recruiting
69 enrolled
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Phase 2 Recruiting
134 enrolled
CAVALRY
Phase 1/2 Recruiting
104 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
BOOSTER
Recruiting
300 enrolled
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Phase 1/2 Recruiting
12 enrolled
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
NICHE
Recruiting
2,300 enrolled
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Phase 1/2 Recruiting
32 enrolled
DISCOVERY
Phase NA Recruiting
500 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Phase 1 Recruiting
18 enrolled
CD4CAR for CD4+ Leukemia and Lymphoma
Phase 1 Recruiting
20 enrolled
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Phase 2 Recruiting
44 enrolled
CAMPERR
Recruiting
7,000 enrolled
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Phase 1/2 Recruiting
50 enrolled
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Phase 1 Recruiting
106 enrolled
Clinical Cohort of Lymphoma Patients in Malawi
Recruiting
800 enrolled
24CT015
Phase 1 Recruiting
33 enrolled
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
Phase NA Recruiting
196 enrolled
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Phase 1/2 Recruiting
70 enrolled
Mosunetuzumab for CLL MRD Clearance
Phase 1/2 Recruiting
40 enrolled
HTLV-OBS
Recruiting
120 enrolled
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Phase 1/2 Recruiting
120 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
OPAL
Phase 1/2 Recruiting
144 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Recruiting
40 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3 Recruiting
900 enrolled
HALO-SCT
Recruiting
1,000 enrolled
Tele@home
Phase NA Recruiting
80 enrolled
ALHERT
Phase NA Recruiting
2,224 enrolled
HEME Home Transfusion Program
Phase NA Recruiting
700 enrolled
Study of Tazemetostat in Lymphoid Malignancies
Phase 1 Recruiting
30 enrolled
uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
Phase 1 Recruiting
12 enrolled